Orphan Drugs Market Size - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 - 2025
Researchmoz added Most up-to-date research on "Orphan Drugs Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 - 2025" to its huge collection of research reports.
Global Orphan Drugs Market: Overview
Orphan diseases can be defined as the medical conditions which impacts a small group of the population and are mostly genetic in nature. For the treatment of these rare diseases pharmaceutical agents are specifically developed which are known as orphan drugs. The market for these orphan drugs is anticipated to grow significantly in the forecast period, owing to the rising prevalence of rare diseases, focus of government and non-government organizations on creating awareness, research and development grants, and fee waivers and tax credits offered, among others.
Global Orphan Drugs Market: Research Methodology
The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of drugs employed in the treatment of rare diseases in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Bn for disease type, product type, distribution channel, and geography for the period 2015 to 2025, considering the macro and micro environmental factors. The revenue generated from each disease type, product type, and distribution channel was calculated by considering the prevalence of rare diseases, orphan drug approvals, regulatory procedures, and the awareness of orphan diseases across all the geographies.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=169893
The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on disease type, product type, distribution channel, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the nurse call systems market in the current and future scenario. The report also provides Porter’s five forces analysis, the acquisitions timeline of orphan drug companies, SWOT analysis of the market, regulatory scenario, comparative analysis of orphan drug policies, rare diseases prevalence, pricing scenario of the orphan drugs, major selling orphan drugs, and drug exclusivity of certain of the orphan drugs, for the market.
Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The study also covers detailed country analysis contributing majorly in the nurse call systems market.
Global Orphan Drugs Market: Competitive Landscape
The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Companies profiled in the nurse call systems market report are Novartis AG, Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd., Pfizer, Inc., Sanofi S.A., Alexion Pharmaceuticals, Inc., Eli Lilly and Company, Novo Nordisk A/S, AstraZeneca plc, Eisai Co., Ltd., Daiichi Sankyo Company Limited, Bayer AG, GlaxoSmithKline plc, Merck & Co., Inc., Johnson & Johnson, Biogen, Inc., Shire plc, and Amgen, Inc., among others.
The Orphan Drugs Market has been segmented as follows:
Orphan Drugs Market, by Disease Type, Revenue (US$ Bn) 2015-2025
Oncology
Gastrointestinal
Pulmonary
Neurology
Hematology
Cardio-vascular
Metabolic disorders
Endocrinology
Infectious diseases
Others
Orphan Drugs Market, by Product Type, Revenue (US$ Bn) 2015-2025
Biologic
Non-biologic
Orphan Drugs Market, by Distribution Channel, Revenue (US$ Bn) 2015-2025
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
Orphan Drugs Market Revenue, by Geography (US$ Bn), 2015-2025
North America
U.S.
Canada
Europe
U.K.
Germany
Spain
France
Italy
Rest of Europe
Rest of the World
Japan
Australia
China
Brazil
South Korea
Others
Table of Content
Section 1 Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
Section 2 Assumptions and Research Methodology
Section 3 Executive Summary
Section 4 Market Overview
4.1. Introduction
4.1.1 Product Type Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Rising prevalence of rare diseases
4.3.1.2. R&D Grants
4.3.1.3. Orphan Drugs provide high return on investments
4.3.1.4. First-mover advantage
4.3.1.5. Focus on awareness programs
4.3.1.6. Tax credits and fee waivers
4.3.2. Restraints
4.3.2.1. High cost of treatment
4.3.2.2. Dearth of trained medical professionals
4.3.2.3. Non-availability of approved drugs worldwide
4.3.2.4. Difficulty in recruiting for clinical trials
4.3.3. Opportunities
4.3.3.1. Unmet clinical needs
4.3.3.2. Strategic mergers and acquisitions
4.3.3.3. Repurposing of drugs
Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/orphan-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2012-2018-report.html/toc
4.3.4. Trends
4.5. Global Orphan Drugs Market Analysis and Forecasts, 2015–2025
4.6. Market Outlook
4.7. Porter's Five Forces Analysis
4.8. Orphan Drug Manufacturing Companies – Acquisitions Timeline
4.9. Orphan Drugs Market- SWOT Analysis
4.10. Regulatory Scenario
4.11. Comparative Analysis of orphan drug policies
4.12. Rare Diseases Prevalence
4.13. Pricing – Orphan Drugs
4.14. Orphan Drugs – Price Volume Analysis
4.15. Major Conferences
4.16. Major selling Orphan drugs
4.17. Orphan Drugs – Drug Exclusivity
4.18. Clinical Trial Analysis
Section 5 Global Orphan Drugs Market Analysis and Forecasts, By Disease Type
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Market Value Forecast By Disease Type, 2015–2025
5.3.1. Oncology
5.3.2. Gastrointestinal
5.3.3. Pulmonary
5.3.4. Neurology
5.3.5. Hematology
5.3.6. Cardiovascular
5.3.7. Metabolic Disorders
5.3.8. Endocrinology
5.3.9. Infectious Diseases
5.3.10. Others
5.4. Market Attractiveness By Disease Type
Continue...
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Global Orphan Drugs Market: Overview
Orphan diseases can be defined as the medical conditions which impacts a small group of the population and are mostly genetic in nature. For the treatment of these rare diseases pharmaceutical agents are specifically developed which are known as orphan drugs. The market for these orphan drugs is anticipated to grow significantly in the forecast period, owing to the rising prevalence of rare diseases, focus of government and non-government organizations on creating awareness, research and development grants, and fee waivers and tax credits offered, among others.
Global Orphan Drugs Market: Research Methodology
The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of drugs employed in the treatment of rare diseases in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Bn for disease type, product type, distribution channel, and geography for the period 2015 to 2025, considering the macro and micro environmental factors. The revenue generated from each disease type, product type, and distribution channel was calculated by considering the prevalence of rare diseases, orphan drug approvals, regulatory procedures, and the awareness of orphan diseases across all the geographies.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=169893
The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on disease type, product type, distribution channel, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the nurse call systems market in the current and future scenario. The report also provides Porter’s five forces analysis, the acquisitions timeline of orphan drug companies, SWOT analysis of the market, regulatory scenario, comparative analysis of orphan drug policies, rare diseases prevalence, pricing scenario of the orphan drugs, major selling orphan drugs, and drug exclusivity of certain of the orphan drugs, for the market.
Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The study also covers detailed country analysis contributing majorly in the nurse call systems market.
Global Orphan Drugs Market: Competitive Landscape
The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Companies profiled in the nurse call systems market report are Novartis AG, Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd., Pfizer, Inc., Sanofi S.A., Alexion Pharmaceuticals, Inc., Eli Lilly and Company, Novo Nordisk A/S, AstraZeneca plc, Eisai Co., Ltd., Daiichi Sankyo Company Limited, Bayer AG, GlaxoSmithKline plc, Merck & Co., Inc., Johnson & Johnson, Biogen, Inc., Shire plc, and Amgen, Inc., among others.
The Orphan Drugs Market has been segmented as follows:
Orphan Drugs Market, by Disease Type, Revenue (US$ Bn) 2015-2025
Oncology
Gastrointestinal
Pulmonary
Neurology
Hematology
Cardio-vascular
Metabolic disorders
Endocrinology
Infectious diseases
Others
Orphan Drugs Market, by Product Type, Revenue (US$ Bn) 2015-2025
Biologic
Non-biologic
Orphan Drugs Market, by Distribution Channel, Revenue (US$ Bn) 2015-2025
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
Orphan Drugs Market Revenue, by Geography (US$ Bn), 2015-2025
North America
U.S.
Canada
Europe
U.K.
Germany
Spain
France
Italy
Rest of Europe
Rest of the World
Japan
Australia
China
Brazil
South Korea
Others
Table of Content
Section 1 Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
Section 2 Assumptions and Research Methodology
Section 3 Executive Summary
Section 4 Market Overview
4.1. Introduction
4.1.1 Product Type Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Rising prevalence of rare diseases
4.3.1.2. R&D Grants
4.3.1.3. Orphan Drugs provide high return on investments
4.3.1.4. First-mover advantage
4.3.1.5. Focus on awareness programs
4.3.1.6. Tax credits and fee waivers
4.3.2. Restraints
4.3.2.1. High cost of treatment
4.3.2.2. Dearth of trained medical professionals
4.3.2.3. Non-availability of approved drugs worldwide
4.3.2.4. Difficulty in recruiting for clinical trials
4.3.3. Opportunities
4.3.3.1. Unmet clinical needs
4.3.3.2. Strategic mergers and acquisitions
4.3.3.3. Repurposing of drugs
Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/orphan-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2012-2018-report.html/toc
4.3.4. Trends
4.5. Global Orphan Drugs Market Analysis and Forecasts, 2015–2025
4.6. Market Outlook
4.7. Porter's Five Forces Analysis
4.8. Orphan Drug Manufacturing Companies – Acquisitions Timeline
4.9. Orphan Drugs Market- SWOT Analysis
4.10. Regulatory Scenario
4.11. Comparative Analysis of orphan drug policies
4.12. Rare Diseases Prevalence
4.13. Pricing – Orphan Drugs
4.14. Orphan Drugs – Price Volume Analysis
4.15. Major Conferences
4.16. Major selling Orphan drugs
4.17. Orphan Drugs – Drug Exclusivity
4.18. Clinical Trial Analysis
Section 5 Global Orphan Drugs Market Analysis and Forecasts, By Disease Type
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Market Value Forecast By Disease Type, 2015–2025
5.3.1. Oncology
5.3.2. Gastrointestinal
5.3.3. Pulmonary
5.3.4. Neurology
5.3.5. Hematology
5.3.6. Cardiovascular
5.3.7. Metabolic Disorders
5.3.8. Endocrinology
5.3.9. Infectious Diseases
5.3.10. Others
5.4. Market Attractiveness By Disease Type
Continue...
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG